Boiron SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boiron SA with three other
companies in this sector in France:
sales of 868.93 million Euro [US$962.27 million]
of which 57%
was Companion Animals),
(789.60 million Euro [US$874.42 million]
of which 44%
was X-rays), and
(367.94 million Euro [US$407.47 million]
of which 55%
During the year ended December of 2018, sales at
Boiron SA were 604.21 million Euro (US$669.12 million).
decrease of 2.2%
versus 2017, when the company's sales were 617.54 million Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Boiron SA had sales
of 617.73 million Euro.
Contributing to the drop in overall sales was the 7.5% decline
in Non-Proprietary Homeopathic Medicines, from 310.59 million Euro to 287.24 million Euro.
There were also decreases in sales in
Other (down 0.1% to 1.39 million Euro)
However, these declines were partially offset by the increase in sales of
Otc Specialities and Other Products (up 3.3% to 315.58 million Euro)